Nor Consult, LLC - Excellence in Clinical Research - Home
Nor Consult, LLC

Excellence in Clinical Research – From Strategy to Approval.

Smart, flexible, and FDA-ready — our clinical research solutions are designed to deliver reliable results with precision, speed, and regulatory confidence.

about-image
About Us

Excellence in Clinical Research – From Strategy to Approval.

Nor Consult is a specialized CRO and consulting partner supporting sponsors across devices, drugs, and combination products. From trial design to global approvals, our senior experts bring academic rigor, regulatory depth, and practical efficiency, helping sponsors achieve FDA- and EMA-ready data while minimizing risk and cost.

  • Expertise across devices, drugs, and combination products
  • FDA- & EMA-ready data with minimized risk and cost
  • Proven track record of efficient, successful studies
  • Support from trial design to global approvals
Learn More About Us
Our Scientific Experts

Meet The Experts

Guided by senior experts with decades of clinical, regulatory, and scientific experience, our leadership team ensures every project is designed and executed with precision.

  • 043-i_4vUTGFkTY

    Branko Kopjar, MD, MSc, PhD, FACE, FAcadTM

    Founder & Managing Member

    I founded Nor Consult, LLC in 2005 with a clear vision: to bring rigorous science and practical wisdom together so that innovators in life sciences can deliver meaningful therapies to patients.

    My career has been a journey through many roles, including professor, biostatistician, clinical epidemiologist, government advisor, and industry consultant. Each role gave me a different lens on the challenges of developing new therapies, and together they inspired me to create Nor Consult. My goal was to create a consultancy that brings together academic rigor and real-world experience, turning complex data into clear strategies that drive innovation and improve patient outcomes.

    Two decades later, I’m proud of our collaborations with start-ups and global leaders alike, driving First-in-Human and pivotal studies, securing key regulatory approvals, and advancing therapies that change patients’ lives.

    In addition to my role at Nor Consult, I serve as an emeritus faculty member at the University of Washington, where, since 1997, I have led research in clinical epidemiology, health outcomes, and medical product evaluation. This balance of academic leadership and hands-on industry work continues to shape our approach: scientifically grounded, results-driven, and always focused on patients.

  • Heagerty_Patrick (1)

    Patrick Heagerty, PhD, FASA

    Senior Scientific Advisor

    Patrick Heagerty, PhD, is a Professor, former Chair of Biostatistics and Director of the Center for Biomedical Statistics at the University of Washington. He is nationally recognized for his deep expertise in clinical trial design and advanced statistical methodologies. Nor Consult has a multi-year partnership with Dr. Heagerty supporting our clients across various therapeutic areas, including medical device and cardiovascular trials.

    His leadership roles, including on the FDA Sentinel Innovation Center, highlight his profound understanding of regulatory requirements and best practices in biostatistics. Dr. Heagerty’s guidance ensures robust study design, precise data analysis, and strategic insights crucial for successful clinical development programs.

    Dr. Heagerty holds a BS in Biology from Cornell University, a MS in Statistics from State University of New York (Albany) and a PhD in Biostatistics from Johns Hopkins. He serves as a statistical editor for the Journal of the American Medical Association (JAMA) and is an elected member of the National Academy of Medicine.

Primary Therapeutic Areas

Focused Expertise in Critical Therapeutic Areas

At Nor Consult, we specialize in high-stakes clinical trials across critical therapeutic areas, delivering outcomes regulators and payers demand.

image Cardiovascular
image Neurovascular
image Orthopedic & Spine
image Wound & Infectious Disease
Testimonials

What Our Clients Say

Trusted by sponsors, investors, and partners worldwide, Nor Consult delivers solutions that withstand regulatory scrutiny and drive program success.

image

Nor Consult is a long-standing partner in running our HIT Reverse HRS clinical trials in Canada and the United States. Their team brings deep expertise, precision, and professionalism to every stage of the process for us as well as with various country regulatory bodies. We’ve been consistently impressed with their ability to balance rigorous standards with practical execution, ensuring that our studies move forward. Their commitment to excellence has made them a trusted extension of our own team.

George Diamantoni

CEO, Hip Innovation Technology

image

At Convatec, we place the highest priority on data quality and patient outcomes in our wound management programs. Partnering with Nor Consult, LLC has been instrumental in achieving both. Their deep expertise in biometrics, attention to detail, and ability to work seamlessly with our clinical and regulatory teams have provided us with reliable insights and a strong foundation for decision-making. We value not only their technical excellence but also their commitment to collaboration and agility. Nor Consult has been a trusted partner in advancing our mission to improve patient lives.

Dr. Beate Hanson

Chief Medical Officer, Convatec Group

image

Nor Consult has been a critical partner in advancing our breakthrough therapies for metastatic cancers. Their deep understanding of the unique complexities of clinical trial designs, combined with their operational precision and strategic insight, has enabled us to execute our trial with rigor and confidence. Their commitment to excellence and collaborative approach make them an indispensable ally as we work to bring new therapies to patients battling cancer.

Joe Loy

CEO, Zetagen Therapeutics

Ready to Accelerate Your Clinical Program?

Partner with senior experts who deliver FDA- and EMA-ready data with efficiency and precision.

Meet Our Experts